|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.58 EUR | -0.78% |
|
-3.51% | -11.85% |
| 12-09 | Guggenheim Downgrades Sanofi to Neutral From Buy | MT |
| 12-09 | US FDA launches fresh safety scrutiny of approved RSV therapies for infants | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bearish |
| Resistance | 86.59 | 90.44 | 92.14 |
| Spread/Res. | -4.57% | -8.64% | -10.32% |
| Spread/Supp. | +2.30% | +6.59% | +5.50% |
| Support | 80.77 | 77.52 | 78.32 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- SAN Stock
- Charts Sanofi
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition